Abstract
Platelet extracellular vesicles (PEVs) generated upon platelet activation may play a role in inflammatory pathologies such as atherosclerosis. Oxidized low-density lipoprotein (oxLDL), a well-known contributor to atherogenesis, activates platelets and presensitizes them for activation by other agonists. We studied the effect of oxLDL on the secretion, composition, and inflammatory functions of PEVs using contemporary EV analytics. Platelets were activated by co-stimulation with thrombin (T) and collagen (C) ± oxLDL and characterized by high-resolution flow cytometry, nanoparticle tracking analysis, proximity extension assay, western blot, and electron microscopy. The effect of PEVs on macrophage differentiation and functionality was examined by analyzing macrophage surface markers, cytokine secretion, and transcriptome. OxLDL upregulated TC-induced formation of CD61+, P-selectin+ and phosphatidylserine+ PEVs. Blocking the scavenger receptor CD36 significantly suppressed the oxLDL+TC-induced PEV formation, and HDL caused a slight but detectable suppression. The inflammatory protein cargo differed between the PEVs from stimulated and unstimulated platelets. Both oxLDL+TC- and TC-induced PEVs enhanced macrophage HLA-DR and CD86 expression and decreased CD11c expression as well as secretion of several cytokines. Pathways related to cell cycle and regulation of gene expression, and immune system signaling were overrepresented in the differentially expressed genes between TC PEV -treated vs. control macrophages and oxLDL+TC PEV -treated vs. control macrophages, respectively. In conclusion, we speculate that oxLDL and activated platelets contribute to proatherogenic processes by increasing the number of PEVs that provide an adhesive and procoagulant surface, contain inflammatory mediators, and subtly finetune the macrophage gene expression.
| Original language | English |
|---|---|
| Article number | 151311 |
| Number of pages | 15 |
| Journal | EUROPEAN JOURNAL OF CELL BIOLOGY |
| Volume | 102 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Jun 2023 |
| Publication type | A1 Journal article-refereed |
Funding
We thank the services of University of Helsinki: EV Core in FIMM Technology Centre supported by the HiLIFE and Biocenter Finland for performing electron microscopy work and Electron Microscopy Unit of the Institute of Biotechnology for providing the facilities. We also thank Core facility Sequencing Unit at FIMM Technology Centre supported by the University of Helsinki and Biocenter Finland, and PLA and Single Cell Facility Swedish SciLifeLab for PEA analysis. Dr. Matti Jauhianen is thanked for kindly providing HDL and the anti-ApoB monoclonal antibody for the experiments. This work was supported by the Academy of Finland [grants 287089 (PRMS and MN), 330486 (PRMS and MP), 332761 (DG and AF), and 332564 (KÖ)]; Business Finland [grant EVE (PRMS and KM)]; Magnus Ehrnrooth Foundation (PRMS); Finnish Foundation for Cardiovascular Research (MN and KÖ); Swedish Research Council [grant 2020–02258 (MKM)]; Medicinska Understödsföreningen Liv och Hälsa rf (PRMS); and Novo Nordisk Foundation [grant NNF19OC0057411 (KÖ)]. The funders had no role in the design of the study, in the collection, analysis, or interpretation of the data, in the writing of the manuscript, or in the decision to publish the results.
Keywords
- Atherosclerosis
- Extracellular vesicle
- Macrophage
- Oxidized low-density lipoprotein
- Platelet
- Transcriptome
Publication forum classification
- Publication forum level 1
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Histology
- Cell Biology